183 related articles for article (PubMed ID: 8882674)
1. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
Goetz MB
AIDS; 1996 Mar; 10(3):335-6. PubMed ID: 8882674
[No Abstract] [Full Text] [Related]
2. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
3. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
Heald AE; Cox GM; Schell WA; Bartlett JA; Perfect JR
AIDS; 1996 Mar; 10(3):263-8. PubMed ID: 8882665
[TBL] [Abstract][Full Text] [Related]
5. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
6. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
[TBL] [Abstract][Full Text] [Related]
7. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
8. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
9. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
10. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
Ruhnke M; Adler A; Müller FM
Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
[No Abstract] [Full Text] [Related]
11. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole prophylaxis in HIV disease, revisited.
Bozzette SA
Clin Infect Dis; 2005 Nov; 41(10):1481-2. PubMed ID: 16231261
[No Abstract] [Full Text] [Related]
13. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Marr KA; White TC; van Burik JA; Bowden RA
Clin Infect Dis; 1997 Oct; 25(4):908-10. PubMed ID: 9356806
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole resistant oral candidiasis in HIV-infected patients.
Tumbarello M; Tacconelli E; Caldarola G; Morace G; Cauda R; Ortona L
Oral Dis; 1997 May; 3 Suppl 1():S110-2. PubMed ID: 9456668
[TBL] [Abstract][Full Text] [Related]
16. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.
Hunter KD; Gibson J; Lockhart P; Pithie A; Bagg J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 May; 85(5):558-64. PubMed ID: 9619674
[TBL] [Abstract][Full Text] [Related]
18. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
Martins MD; Lozano-Chiu M; Rex JH
Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
[TBL] [Abstract][Full Text] [Related]
19. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
20. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
